Treatment of diabetes mellitus with amylin agonists
AssigneeAmylin Pharmaceuticals, Inc.
InventorGarth J. S. Cooper
Life of this patent
Estimating the term…
Abstract
Novel methods for treating diabetes mellitus and hyperglycemia are described which comprise administering to a diabetic or hypoglycemic subject an amount of an amylin agonist effective to induce amylin activity in said subject. Various amylin agonist compounds, and therapeutic methods utilizing such compounds, are also disclosed.
Claims25
A method of treating diabetes mellitus in a subject comprising administering to said subject an amount of an amylin agonist effective to induce amylin activity in said subject.
A method of treating hypoglycemia in a subject comprising administering to said subject an amount of an amylin agonist effective to induce amylin activity in said subject.
A method of treating diabetes mellitus comprising administering a pharmaceutical composition comprising an amylin agonist and an insulin.
Dependencies are inferred from the claim text.